Letter to the editor: 'Amiodarone-induced phlebitis: incidence and adherence to a clinical practice guideline'
Eur J Cardiovasc Nurs
.
2023 Dec 14;22(8):e133-e134.
doi: 10.1093/eurjcn/zvad057.
Authors
Hedayat Jafari
1
,
Vida Shafipour
1
,
Mahsa Kamali
2
,
Amirabbas Mollaei
3
Affiliations
1
Traditional and Complementary Medicine Research Center, Addiction Institute, Mazandaran University of Medical Sciences, Sari, Iran.
2
Cardiovascular Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
3
Department of Medical-Surgical Nursing, School of Nursing and Midwifery, Guilan University of Medical Sciences, Rasht, Iran.
PMID:
37337657
DOI:
10.1093/eurjcn/zvad057
No abstract available
MeSH terms
Amiodarone* / adverse effects
Anti-Arrhythmia Agents / adverse effects
Guideline Adherence
Humans
Incidence
Phlebitis* / chemically induced
Phlebitis* / epidemiology
Substances
Amiodarone
Anti-Arrhythmia Agents
Grants and funding
commercial